Risk stratification and early detection biomarkers for precision HCC screening

YT Lee, N Fujiwara, JD Yang, Y Hoshida - Hepatology, 2023 - journals.lww.com
Hepatocellular carcinoma (HCC) mortality remains high primarily due to late diagnosis as a
consequence of failed early detection. Professional societies recommend semi‐annual HCC …

The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection

JH Yu, SG Cho, YJ Jin, JW Lee - Clinical and molecular …, 2021 - pmc.ncbi.nlm.nih.gov
Chronic hepatitis B (CHB) seriously threatens human health. About 820,000 deaths annually
are due to related complications such as hepatitis B and hepatocellular carcinoma (HCC) …

[HTML][HTML] Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir-vs. entecavir-based regimens: Individual patient data meta-analysis

WM Choi, TCF Yip, GLH Wong, WR Kim, LJ Yee… - Journal of …, 2023 - Elsevier
Background & Aims The comparative risk of hepatocellular carcinoma (HCC) in patients with
chronic hepatitis B (CHB) receiving tenofovir disoproxil fumarate (TDF) vs. entecavir (ETV) …

HCC prediction models in chronic hepatitis B patients receiving entecavir or tenofovir: a systematic review and meta-analysis

X Xu, L Jiang, Y Zeng, L Pan, Z Lou, B Ruan - Virology Journal, 2023 - Springer
Background Our study aimed to compare the predictive performance of different
hepatocellular carcinoma (HCC) prediction models in chronic hepatitis B patients receiving …

Clinical and molecular prediction of hepatocellular carcinoma risk

N Kubota, N Fujiwara, Y Hoshida - Journal of Clinical Medicine, 2020 - mdpi.com
Prediction of hepatocellular carcinoma (HCC) risk becomes increasingly important with
recently emerging HCC-predisposing conditions, namely non-alcoholic fatty liver disease …

[HTML][HTML] Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy

BK Kim, SH Ahn - Journal of the Formosan Medical Association, 2023 - Elsevier
Chronic hepatitis B virus (HBV) infection, which ultimately leads to liver cirrhosis, hepatic
decompensation, and hepatocellular carcinoma (HCC), remains a significant disease …

[HTML][HTML] Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients

J Guo, XS Gao - World Journal of Clinical Cases, 2021 - ncbi.nlm.nih.gov
Chronic hepatitis B (CHB)-related hepatocellular carcinoma (HCC) is a major health
problem in Asian-Pacific regions. Antiviral therapy reduces, but does not completely prevent …

External validation of hepatocellular carcinoma risk scores in patients with chronic hepatitis B virus infection in China

T Lou, B Li, P Xiong, C Jin, Y Chen - Journal of Viral Hepatitis, 2021 - Wiley Online Library
Several scores have been proposed in untreated or treated patients with chronic hepatitis B
(CHB) to predict risks of hepatocellular carcinoma (HCC) occurrence. However, it is still …

[HTML][HTML] Diagnóstico y tratamiento de la hepatitis B.¿ Qué pueden aportar las instituciones penitenciarias?

M Vergara - Revista Española de Sanidad Penitenciaria, 2021 - SciELO Espana
Hepatitis B is a parenterally and sexually transmitted infection. Vaccination for the disease is
highly effective, and its inclusion in Spain as part of a systematic and universal schedule for …

[HTML][HTML] Diagnosis and treatment of hepatitis B. What contributions can prisons make?

M Vergara - Revista espanola de sanidad penitenciaria, 2021 - ncbi.nlm.nih.gov
Hepatitis B is a parenterally and sexually transmitted infection. Vaccination for the disease is
highly effective, and its inclusion in Spain as part of a systematic and universal schedule for …